Cytosorbents Corporation
CTSO
$1.10
-$0.03-2.66%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.33M | -4.14M | -6.36M | -5.83M | -9.19M |
| Total Depreciation and Amortization | 428.80K | 446.50K | 443.20K | 792.70K | 462.60K |
| Total Amortization of Deferred Charges | 190.40K | -10.70K | 10.70K | -- | -- |
| Total Other Non-Cash Items | -2.02M | 1.68M | 2.44M | -1.44M | 3.36M |
| Change in Net Operating Assets | 1.28M | -2.77M | -1.37M | 74.30K | 167.70K |
| Cash from Operations | -2.46M | -4.79M | -4.83M | -6.41M | -5.21M |
| Capital Expenditure | -151.70K | -18.20K | -45.20K | -95.50K | -142.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -146.60K | -101.60K | -81.80K | -40.40K | -115.30K |
| Cash from Investing | -298.40K | -119.90K | -127.00K | -135.90K | -257.70K |
| Total Debt Issued | 0.00 | 15.00M | -- | -- | -- |
| Total Debt Repaid | 0.00 | -4.38M | -625.00K | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 53.20K | 12.21M | 648.30K |
| Repurchase of Common Stock | -41.50K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -57.60K | -790.40K | -- | -- | -- |
| Cash from Financing | -99.00K | 9.83M | -571.80K | 12.21M | 648.30K |
| Foreign Exchange rate Adjustments | 85.20K | -69.80K | 5.80K | -98.60K | 23.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.77M | 4.85M | -5.52M | 5.57M | -4.79M |
